1/49
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Epidemiology
Incidence - approx. 8,920 cases in 2026
Deaths- approx. 1,100
Less common than non-Hodgkin lymphoma
Death rate declining
Slightly higher incidence in Non-Hispanic whites and blacks
Why is there a decrease in deaths?
Lower incidence, advanced tx., improved survival for HIV- associated lymphoma
Peak incidence in what ages?
20-34 and 55+
Median age at dx
39
___ of cases involve children under age 17, rare in those under age 5
12%
Slightly more prevalent in which gender?
Male
Etiology
Cause unknown
Epstein-Barr virus
Infectious mononucleosis
Family history (siblings of patients with Hodgkins at higher risk)
Reed Sternberg cells
An individual’s genetic makeup
Environmental exposures
Infectious agents
Known risk factors
Severely altered immune function:
◦ Immunosuppressants given for organ transplant patients
◦ Autoimmune disorders: Sjögren syndrome, systemic lupus, rheumatoid arthritis
◦ HIV (due to weakening the immune system)
◦ Helicobacter pylori (by continuously activating the immune system)
◦ Hepatitis C
Prognostic Indicators
Stage at diagnosis
Age
B symptoms
Preservation of fertility in both females and males
Clinical presentation
Most present with painless lymphadenopathy and are asymptomatic
Painless mass is most often discovered in supraclavicular, cervical, and mediastinal lymph node areas (can include lumps in the neck, underarm, or groin)
◦ Chest pain
◦ Shortness of breath
◦ Abdominal fullness
◦ Loss of appetite
◦ Itching
◦ Night sweats
◦ Fatigue
◦ Unexplained weight loss
◦ Intermittent fever
What is the most common sign?
A painless mass found by the patient, above the diaphragm
What are “B” symptoms?
Specific symptoms associated with Hodgkin lymphoma
1. Unexplained weight loss of more than 10% of body weight in the 6 months before
2. Frequent, drenching night sweats
3. Unexplained fevers higher than 100.4 degrees
• Generalized pruritis and pain with alcohol ingestion
• Shortness of breath, cough, or chest discomfort
How many patients experience B symptoms before diagnosis?
1/3
Detection and Diagnosis
H&P
Radiographic examinations
Chest x-ray (mediastinal masses are often found on routine chest x-rays)
CT
MRI
PET
Laboratory studies
CBC
Complete platelet count
Liver and renal functions
What conditions can indicate bone marrow involvement?
Anemia, leukopenia, thrombocytosis, and lymphopenia
Bone marrow biopsies are reserved for which patients? Why
Later-stage disease and subdiaphragmatic disease
Because few patients with Hodgkin lymphoma have bone marrow involvement
Abnormal laboratory studies that may indicate Hodgkin lymphoma
• Low blood albumin level below 4
• High erythrocyte sedimentation rate
• High white blood cell count above 15,000
• Low red blood cell count, hemoglobin level below 10.5
• Low blood lymphocyte count below 600
The WHO classification system divides Hodgkin into two main categories:
Classic Hodgkin lymphoma - (approx. 95%)
Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) - (5%)
4 subcategories of Classic Hodgkin lymphoma
• Nodular Sclerosing Hodgkin lymphoma*
• Mixed Cellularity Hodgkin lymphoma*
• Lymphocyte –rich Hodgkin lymphoma
• Lymphocyte-depleted Hodgkin lymphoma (rarest of 4 types)
Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL)
Characterized by variants of Reed-Sternberg cells called popcorn cells
Presents with disease in the lymph nodes of neck and axilla
80% 10-year survival for stages I and II
Staging system
Ann Arbor Staging System:
A The patient does not have B symptoms.
B The patient has B symptoms.
E Extranodal disease is present.
S Disease is found in the spleen.
Routes of Spread
Predictable, contiguous pattern of spread that mimics the route of the lymphatic system
◦ If outside of lymph system, it is next to the involved sites
◦ Rate of progression not predictable
◦ In advanced stages, may spread to viscera, spleen, bone marrow, or other organs
Primary treatment modality for early-stage disease?
Chemotherapy
Pts with adverse reactions to chemo are given which treatment?
EBRT alone
ABVD is the standard treatment today (proven more effective and less toxic than MOPP)
doxorubicin (Adriamycin), bleomycin, vincristine, and dacarbazine
Patients diagnosed with advanced stages are treated with ________ because combined modality yields better results
Chemotherapy regimen and adjuvant radiation therapy
Mantle field
Disease above diaphragm
Field includes the cervical, submandibular, axillary, supraclavicular, infraclavicular, mediastinal, and hilar lymph nodes
Large fields needed to encompass nodes in neck, chest, and axilla, but sparing healthy tissue
Mantle field borders
Sup: lower mandible and mastoid tips (chin hyperextended)
Inf: T9 to interspace
Lat: flash beyond axillary nodes
Abdominal or Paraaortic Fields
The spleen, paraaortic, and retroperitoneal nodes are treated
Treatment of the mantle and abdominal fields without the pelvic portion is termed subtotal nodal irradiation
A spinal block may be added superiorly on the abdominal field to protect the spinal cord from overdose
Why must the left kidney be protected if the spleen is treated?
Because the right kidney receives dose
Abdominal/Paraaortic field borders
Sup: Mid T10-T11
Inf: L4-L5
Lat: 9-10 cm wide midline
Pelvic Irradiation (Inverted Y field)
Shielding blocks are used to protect bone marrow, the bowel, and the bladder
Can cause concern for patients who desire to preserve fertility
Pelvic field borders
Sup: L5, Inf: 2 cm below ischial tuberosity
Lat: 2 cm beyond pelvic inlet
Total nodal radiation
Encompasses both mantle and inverted Y fields
Patients receiving multiple treatment fields usually undergo ________ treatment for better tolerance
Sequential
Treatment areas that only encompass the areas of known disease are called
Involved field radiation therapy
When the field includes areas of known disease and contiguous uninvolved lymph nodes is called
Extended field radiation therapy
For patients with a favorable prognosis, treatment to the pelvic region is avoided. Why?
To preserve fertility
If chemo and radiation therapy fail, patients may undergo ________
Autologous bone marrow and peripheral blood stem cell transplants
Involved-Node Radiotherapy field volumes
Include only the initially involved nodes with a 1cm margin and modifications to block organs at risk
Involved-Site Radiotherapy field volumes
Include all initial disease sites after chemotherapy, If treated with EBRT alone, the ISRT field margins should increase by 2–5cm superiorly and inferiorly, accounting for OARs
Doses of EBRT alone
30-36 Gy to involved sites with 6-MV to 10-MV
Doses of sites with potential subclinical involvement
25-30 Gy
Doses for EBRT with chemo
20-30 Gy for non-bulky disease
30-36 Gy for bulky sites
Radiation Side Effects
◦ Fatigue
◦ Alopecia
◦ Skin erythema
◦ Esophagitis
◦ Altered taste
◦ Dysphagia
◦ Dry cough
◦ Nausea
◦ Vomiting
◦ Diarrhea
Late Complications from EBRT
◦ Hypothyroidism
◦ Cardiac disease
◦ Radiation pneumonitis
◦ Increased dental caries
◦ Xerostomia
◦ Secondary cancer
◦ Infections
◦ Thyroid issues
◦ Lung damage
◦ Lhermitte syndrome - numbness/electrical sensations that run down the body to the limbs
◦ Second malignancies
◦ Xerospermia - loss of sperm
Hodgkin lymphoma is one of the most curable types of cancer and has been proven to respond to chemotherapy and radiation therapy at a lower dose than other types of tumors
True
Overall 5-year survival
89%
Factors that may decrease survival/ be a cause for more aggressive treatment
◦ Male gender
◦ Age 45 years old or older
◦ B symptoms
◦ Markedly abnormal laboratory results
Extranodal disease
Rare